BSE: 524506 - Coral Laboratories Limited

半年間の収益性: -19.84%
配当利回り: +0.23%

プロモーションスケジュール Coral Laboratories Limited


会社について Coral Laboratories Limited

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally.

さらに詳しく
The company offers antibiotics/antibacterial products, including antifungal, antiemetic, analgesics/antipyretic/antiinflammatory, antispasmodic, anticold, antiallergic, antiasthmatic, antidiabetic, antiemetics, anthelmentic, thyroid, and antiprotozoal/antiamebic products; antimalarial drugs, antipsychotic drugs, gastro-intestinal drugs, kits, muscle relaxants, cough suppressant/expectorant products, cardiovascular medicines, oral antiseptic preparations, mouthwashes, calcium preparations, and appetizers; and nutritional, protein, and iron supplements, as well as other products. It also provides cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. It provides its products in various dosage forms, including tablets, capsules, low RH facilities, liquid orals, liquids and powders, dry syrups, drops, ointment and creams, gels and lotions, granules powders, injectables, nasal sprays, and suppositories. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.23
Дивиденд ао 2
Сайт http://corallab.com
Цена ао 757.6
1日あたりの価格変動: -2.54% (747.35)
週ごとの価格変動: -1.55% (739.8)
月ごとの料金変更: -9.81% (807.6)
3ヶ月間の価格変動: -4.44% (762.2)
半年間の価格変動: -19.84% (908.6)
年間の価格変動: +93.76% (375.9)
3年間の価格推移: +114.98% (338.8)
5年間の価格推移: +432.03% (136.9)
10年間の価格推移: 0% (728.35)
年初からの価格変動: -6.35% (777.7)

過小評価

名前 意味 学年
P/S 1.72 8
P/BV 0.7979 9
P/E 8.97 9
EV/EBITDA 0 0
合計: 8

効率

名前 意味 学年
ROA, % 8.31 3
ROE, % 9.5 3
合計: 2

配当金

名前 意味 学年
Div yield, % 0.23 0.58
DSI 0.9286 9.29
合計: 1.91

義務

名前 意味 学年
Debt/EBITDA 0 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % 16.32 3
収益性 Ebitda, % 0 5
収益性 EPS, % 121.44 10
合計: 7.6

スーパーバイザー 役職 支払い 生年
Mr. Girish Madanlal Dhameja Whole-Time Director 1981 (44 年)
Ms. Sushma Shashi Kadkade CFO & Non-Exec. Director 1976 (49 年)
Ms. Ruchi Anjaria Company Sec. & Compliance Officer
Mr. Kapil K. Shah Exec. Officer

住所: India, Mumbai, #3B Patanwala Industrial Estate - Googleマップで開く, Yandexマップを開く
Webサイト: http://corallab.com